Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Solange Glaize, Louis Grever, Chuck Abdalian, Adam Rosenberg, Jay Therrien, and More

Premium

Agilent Technologies has appointed Solange Glaize to serve as VP and chief accounting officer, effective immediately. Glaize has already held various posts at Agilent, including senior director of finance for the life sciences solutions unit, and VP of finance and group CFO of the Life Sciences Group. Glaize will receive an increase in her base salary to $285,000.


IntegenX has appointed Louis Grever to its board of directors. Grever is a former executive assistant director of the Science and Technology Branch of the Federal Bureau of Investigation, where he served for 24 years in various roles.


Knome has expanded its management team, hiring Chuck Abdalian to chief financial officer, Adam Rosenberg to senior vice president and head of corporate development, and Jay Therrien to senior vice president and head of global sales.

Abdalian most recently served as senior vice president of finance and chief financial officer of Molecular Insight Pharmaceuticals. He also served as senior vice president of finance and chief financial officer at Coley Pharmaceutical Group, CEO of Pelias Technologies, and chief financial officer of Emisphere Technologies. He holds a BS from Norwich University and an MBA from the Wharton School at the University of Pennsylvania.

Rosenberg, prior to joining Knome, advised emerging companies as a director and consultant and also co-founded the start-up Clean Membranes. He has also served as CEO of Link Medicine Corporation and helped launch the law firm Faber Daeufer & Rosenberg PC. He holds a BA from Whittier College and a JD from University of Virginia School of Law.

Thierrien was previously vice president of commercial operations and sequencing at Life Technologies. He has also held various positions at Illumina, including director of sales for Asia Pacific and Japan. He holds a BS from the University of Illinois at Urbana-Champaign and a PhD from the University of Kansas.


Knome has also appointed Hugh Reinhoff to its scientific advisory board. Reinhoff is currently a managing director of Life Science Venture Partners, an adjunct scientist at the Children's Hospital Oakland Research Institute, and CEO of FerroKin BioSciences. He founded the nonprofit MyDaughtersDNA.org, and previously served as CEO and chairman of the board at DNA Sciences. He was also founding director of Healtheon Corporation, now known as WebMD Health. He holds an MD from the Johns Hopkins University School of Medicine.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.